TLR5
Toll-like receptor 5
Also known as: FLJ10052, MGC126430, MGC126431, SLEB1, TIL3, TLR5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O60602
- Gene
- TLR5
- Ensembl
- ENSG00000187554
- Chromosome
- 1
- Canonical length
- 858 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the toll-like receptor (TLR) family, which plays a fundamental role in pathogen recognition and activation of innate immune responses. These receptors recognize distinct pathogen-associated molecular patterns that are expressed on infectious agents. The protein encoded by this gene recognizes bacterial flagellin, the principal component of bacterial flagella and a virulence factor. The activation of this receptor mobilizes the nuclear factor NF-kappaB, which in turn activates a host of inflammatory-related target genes. Mutations in this gene have been associated with both resistance and susceptibility to systemic lupus erythematosus, and susceptibility to Legionnaire disease.[provided by RefSeq, Dec 2009]
Canonical amino-acid sequenceUniProt
858 residues, UniProt reviewed canonical sequence.
>O60602|TLR5
1 MGDHLDLLLG VVLMAGPVFG IPSCSFDGRI AFYRFCNLTQ VPQVLNTTER LLLSFNYIRT
61 VTASSFPFLE QLQLLELGSQ YTPLTIDKEA FRNLPNLRIL DLGSSKIYFL HPDAFQGLFH
121 LFELRLYFCG LSDAVLKDGY FRNLKALTRL DLSKNQIRSL YLHPSFGKLN SLKSIDFSSN
181 QIFLVCEHEL EPLQGKTLSF FSLAANSLYS RVSVDWGKCM NPFRNMVLEI LDVSGNGWTV
241 DITGNFSNAI SKSQAFSLIL AHHIMGAGFG FHNIKDPDQN TFAGLARSSV RHLDLSHGFV
301 FSLNSRVFET LKDLKVLNLA YNKINKIADE AFYGLDNLQV LNLSYNLLGE LYSSNFYGLP
361 KVAYIDLQKN HIAIIQDQTF KFLEKLQTLD LRDNALTTIH FIPSIPDIFL SGNKLVTLPK
421 INLTANLIHL SENRLENLDI LYFLLRVPHL QILILNQNRF SSCSGDQTPS ENPSLEQLFL
481 GENMLQLAWE TELCWDVFEG LSHLQVLYLN HNYLNSLPPG VFSHLTALRG LSLNSNRLTV
541 LSHNDLPANL EILDISRNQL LAPNPDVFVS LSVLDITHNK FICECELSTF INWLNHTNVT
601 IAGPPADIYC VYPDSFSGVS LFSLSTEGCD EEEVLKSLKF SLFIVCTVTL TLFLMTILTV
661 TKFRGFCFIC YKTAQRLVFK DHPQGTEPDM YKYDAYLCFS SKDFTWVQNA LLKHLDTQYS
721 DQNRFNLCFE ERDFVPGENR IANIQDAIWN SRKIVCLVSR HFLRDGWCLE AFSYAQGRCL
781 SDLNSALIMV VVGSLSQYQL MKHQSIRGFV QKQQYLRWPE DLQDVGWFLH KLSQQILKKE
841 KEKKKDNNIP LQTVATISLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TLR5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- ovary: 13 nTPM
- salivary gland: 9.7 nTPM
- breast: 8 nTPM
- lung: 5.9 nTPM
- esophagus: 5.8 nTPM
- cervix: 5.7 nTPM
Single-cell type
- neutrophils: 253 nCPM
- microglia: 76 nCPM
- endometrial luminal cells: 48 nCPM
- prostatic club cells: 48 nCPM
- macrophages: 46 nCPM
- salivary acinar cells: 43 nCPM
Immune cell
- classical monocyte: 31 nTPM
- intermediate monocyte: 28 nTPM
- neutrophil: 25 nTPM
- myeloid DC: 23 nTPM
- non-classical monocyte: 13 nTPM
- total PBMC: 11 nTPM
Brain region
- white matter: 8.2 nTPM
- medulla oblongata: 5.5 nTPM
- pons: 5.5 nTPM
- thalamus: 5.2 nTPM
- spinal cord: 4.4 nTPM
- midbrain: 3.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TLR5.
Disease | AllUniProt
Conditions TLR5 is implicated in, by any mechanism.
- Systemic lupus erythematosus 1 (SLEB1) MIM:601744
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 131 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Systemic lupus erythematosus, susceptibility to, 1
Disease | ImmuneIEDB
Conditions an epitope on TLR5 was assayed in.
- influenza T cell
ReferencesPubMed · IEDB
Publications for TLR5 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
Reference: T cellIEDB
1 publication
- High level of cross-reactivity in influenza virus hemagglutinin-specific CD4+ T-cell response: implications for the initiation of autoimmune response in multiple sclerosis.
2005 · J Neuroimmunol · RCR 0.8 · 40 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.38
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.39
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to lipopolysaccharide
- cellular response to mechanical stimulus
- inflammatory response
- innate immune response
- male gonad development
- positive regulation of interleukin-8 production
- positive regulation of nitric oxide biosynthetic process
- toll-like receptor 5 signaling pathway
- toll-like receptor signaling pathway
Molecular functions
- interleukin-1 receptor binding
- pattern recognition receptor activity
- signaling receptor activity
- transmembrane signaling receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Toll/interleukin-1 receptor homology (TIR) domain
- Cysteine-rich flanking region, C-terminal
- Leucine-rich repeat
- Leucine-rich repeat, typical subtype
- Toll-like receptor
- Leucine-rich repeat domain superfamily
- Toll/interleukin-1 receptor homology (TIR) domain superfamily
- Leucine Rich Repeat
- TIR domain
- Leucine rich repeat
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TLR5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TLR5 as an antibody target. Whether an autoantibody or antibody against TLR5 could matter depends on whether native TLR5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TLR5 is annotated at the cell surface, where native TLR5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TLR5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...